244 related articles for article (PubMed ID: 27082941)
1. Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells.
Rauner M; Franke K; Murray M; Singh RP; Hiram-Bab S; Platzbecker U; Gassmann M; Socolovsky M; Neumann D; Gabet Y; Chavakis T; Hofbauer LC; Wielockx B
J Bone Miner Res; 2016 Oct; 31(10):1877-1887. PubMed ID: 27082941
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2.
Hulley PA; Bishop T; Vernet A; Schneider JE; Edwards JR; Athanasou NA; Knowles HJ
J Pathol; 2017 Jul; 242(3):322-333. PubMed ID: 28418093
[TBL] [Abstract][Full Text] [Related]
3. Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin.
Kobayashi H; Liu Q; Binns TC; Urrutia AA; Davidoff O; Kapitsinou PP; Pfaff AS; Olauson H; Wernerson A; Fogo AB; Fong GH; Gross KW; Haase VH
J Clin Invest; 2016 May; 126(5):1926-38. PubMed ID: 27088801
[TBL] [Abstract][Full Text] [Related]
4. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.
Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B
Blood; 2013 Feb; 121(8):1436-45. PubMed ID: 23264599
[TBL] [Abstract][Full Text] [Related]
6. Conditional disruption of the prolyl hydroxylase domain-containing protein 2 (Phd2) gene defines its key role in skeletal development.
Cheng S; Xing W; Pourteymoor S; Mohan S
J Bone Miner Res; 2014 Oct; 29(10):2276-86. PubMed ID: 24753072
[TBL] [Abstract][Full Text] [Related]
7. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins.
Takeda K; Aguila HL; Parikh NS; Li X; Lamothe K; Duan LJ; Takeda H; Lee FS; Fong GH
Blood; 2008 Mar; 111(6):3229-35. PubMed ID: 18056838
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of HIF-prolyl 4-hydroxylases 1, 2 and 3 in NG2-expressing cells induces HIF2-mediated neurovascular expansion independent of erythropoietin.
Urrutia AA; Guan N; Mesa-Ciller C; Afzal A; Davidoff O; Haase VH
Acta Physiol (Oxf); 2021 Jan; 231(1):e13547. PubMed ID: 32846048
[TBL] [Abstract][Full Text] [Related]
9. Prolyl-4-hydroxylases 2 and 3 control erythropoietin production in renin-expressing cells of mouse kidneys.
Broeker KAE; Fuchs MAA; Schrankl J; Lehrmann C; Schley G; Todorov VT; Hugo C; Wagner C; Kurtz A
J Physiol; 2022 Feb; 600(3):671-694. PubMed ID: 34863041
[TBL] [Abstract][Full Text] [Related]
10. Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Regulates Chondrocyte Differentiation and Secondary Ossification in Mice.
Cheng S; Aghajanian P; Pourteymoor S; Alarcon C; Mohan S
Sci Rep; 2016 Oct; 6():35748. PubMed ID: 27775044
[TBL] [Abstract][Full Text] [Related]
11. Conditional Deletion of Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Gene Reveals Its Essential Role in Chondrocyte Function and Endochondral Bone Formation.
Cheng S; Xing W; Pourteymoor S; Schulte J; Mohan S
Endocrinology; 2016 Jan; 157(1):127-40. PubMed ID: 26562260
[TBL] [Abstract][Full Text] [Related]
12. HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress.
Singh RP; Franke K; Kalucka J; Mamlouk S; Muschter A; Gembarska A; Grinenko T; Willam C; Naumann R; Anastassiadis K; Stewart AF; Bornstein S; Chavakis T; Breier G; Waskow C; Wielockx B
Blood; 2013 Jun; 121(26):5158-66. PubMed ID: 23667053
[TBL] [Abstract][Full Text] [Related]
13. Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice.
Li X; Sutherland S; Takeda K; Fong GH; Lee FS
Blood Cells Mol Dis; 2010 Jun; 45(1):9-19. PubMed ID: 20400342
[TBL] [Abstract][Full Text] [Related]
14. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
Lappin TR; Lee FS
Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin in bone homeostasis-Implications for efficacious anemia therapy.
Lappin KM; Mills KI; Lappin TR
Stem Cells Transl Med; 2021 Jun; 10(6):836-843. PubMed ID: 33475252
[TBL] [Abstract][Full Text] [Related]
16. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin.
Wu C; Rankin EB; Castellini L; Alcudia JF; LaGory EL; Andersen R; Rhodes SD; Wilson TL; Mohammad KS; Castillo AB; Guise TA; Schipani E; Giaccia AJ
Genes Dev; 2015 Apr; 29(8):817-31. PubMed ID: 25846796
[TBL] [Abstract][Full Text] [Related]
17. Neuronal prolyl-4-hydroxylase 2 deficiency improves cognitive abilities in a murine model of cerebral hypoperfusion.
Gruneberg D; Montellano FA; Plaschke K; Li L; Marti HH; Kunze R
Exp Neurol; 2016 Dec; 286():93-106. PubMed ID: 27720797
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression.
Stockmann C; Fandrey J
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):968-79. PubMed ID: 17002676
[TBL] [Abstract][Full Text] [Related]
19. Roles of renal erythropoietin-producing (REP) cells in the maintenance of systemic oxygen homeostasis.
Suzuki N; Yamamoto M
Pflugers Arch; 2016 Jan; 468(1):3-12. PubMed ID: 26452589
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
